HYDRIX ORD
Hydrix secures $2.5m deal to collaborate on development of SynCardia’s total artificial heart technology
Hydrix secures a $2.5m deal with SynCardia to collaborate on Emperor total artificial heart tech, launching a multi-stage development program.
Hydrix welcomes first AngelMed Guardian device implant in the US
Product innovation company Hydrix (ASX: HYD) received a welcome operational boost yesterday after one of the devices it distributes was successfully implanted into a patient with a prior acute coronary syndrome. Hydrix’s partner and product manufacturer, Angel Medical Systems (AngelMed), told the market that a former ALERTS Study patient in the United States had received […]
Hydrix confirms four Asia-Pacific cardiac patients receive AngelMed Guardian heart attack alert implant
Cardiovascular technology promoter Hydrix (ASX: HYD) has confirmed its AngelMed Guardian implantable heart attack alerting device has been used for the first time in four separate surgical procedures at a Singapore hospital. The surgeries were performed over three days last week on patients chosen based on their previous medical history and perceived benefits they would […]